perifosine has been researched along with Sarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, W; Poradosu, E; Ratain, MJ; Zhang, W | 1 |
| Blackstein, M; Bramwell, V; Dancey, J; Dore, N; Eisenhauer, E; Knowling, M; Matthews, S; Tozer, R | 1 |
| Bailey, HH; Erlichman, C; Ettinger, DS; Fracasso, PM; Mahoney, MR; Maples, WJ; Okuno, SH; Traynor, AM | 1 |
2 trial(s) available for perifosine and Sarcoma
| Article | Year |
|---|---|
A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial.
Topics: Academies and Institutes; Adult; Aged; Antineoplastic Agents; Canada; Disease Progression; Female; Humans; Male; Middle Aged; Neoplasms; Phosphorylcholine; Sarcoma | 2006 |
Phase II study of daily oral perifosine in patients with advanced soft tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Phosphorylcholine; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Treatment Outcome | 2006 |
1 other study(ies) available for perifosine and Sarcoma
| Article | Year |
|---|---|
Genome-wide identification of genetic determinants for the cytotoxicity of perifosine.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Gene Dosage; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Genome, Human; Humans; MAP Kinase Signaling System; Oligonucleotide Array Sequence Analysis; Phosphorylcholine; Polymorphism, Single Nucleotide; Sarcoma; Software | 2008 |